Valganciclovir Hydrochloride
Valganciclovir Hydrochloride is a premium-grade, high-purity antiviral active pharmaceutical ingredient (API) with CAS number 175865-59-5. This highly bioavailable L-valyl ester prodrug is widely utilized across the global pharmaceutical sector to manufacture clinical-strength oral tablets and specialized cytomegalovirus (CMV) prevention therapies.
Description
Comprehensive Product Overview of Valganciclovir Hydrochloride
Exceptional digestibility and rapid absorption provide a major competitive advantage in the formulation of therapeutic treatments. This active pharmaceutical ingredient works by providing the essential structural mechanisms—specifically converting into ganciclovir post-administration to target viral DNA polymerases—needed for effective systemic modulation. It helps manufacturers achieve potent therapeutic profiles in anti-viral products without sacrificing formula stability. For instance, Valganciclovir Hydrochloride is frequently used as a primary ingredient in clinical-strength post-transplant infection therapies. Consequently, it improves the final clinical efficacy of acute cytomegalovirus eradication routines. As a result, Zyntex ensures low heavy metal content and strict microbiological control for our supply, ensuring maximum safety during your manufacturing cycle.
Moreover, Zyntex supplies specialized fine crystalline powder grades for the medical research and fine chemical compounding industries. This compound acts as a critical structural asset, helping to enhance the systemic defense mechanisms of biological matrices undergoing severe viral exposure. It pushes the boundaries of medical science by offering a highly stable active source that does not affect the final blend’s processing parameters during tablet compression. At the same time, it serves as a crucial biomaterial matrix in the synthesis of specialized prolonged-release matrices and targeted prescription intermediates. In short, our product serves as a dependable “structural matrix.” It supports both the vitality of the human body and the precision of modern biomedical engineering.
Recently, scientific interest in its application for eco-friendly target-delivery nano-carriers and advanced micro-encapsulation dosing layers has grown. It provides a highly targeted and potent alternative to generic antiviral parameters that cause widespread systemic inconsistency. Because of this, Zyntex offers refined chemical grades designed to meet the rigorous specifications of modern sustainable pharmaceutical research. Ultimately, choosing Zyntex secures a reliable and transparent chemical supply chain. We balance core chemistry expertise with rigorous quality monitoring. To conclude, our commitment ensures your Valganciclovir Hydrochloride manufacturing processes achieve the highest levels of clinical performance and purity.
Key Industrial Applications for Valganciclovir Hydrochloride
This high-purity bioavailable antiviral active substance is essential in these four primary sectors:
💊 Antiviral Tablets
Primary active source for manufacturing standard film-coated oral CMV prescription pills. Thus, it provides essential support for localized systemic viral regulation.
🏥 Post-Transplant Care
Key drug block utilized for preventative therapeutic care lines in organ transplant patients. Undoubtedly, it is vital for enhancing patient defense benchmarks.
🔬 Clinical Bio-Assays
Used for targeted polymerases interaction testing and cell replication inhibition models. Consequently, it is vital for high-performance research control.
🧪 Fine Drug Synthesis
Acts as an essential reference standard block for modern esterification and chemical synthesis trails. Specifically, it supports rapid compounding and formula clarity.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Valganciclovir Hydrochloride (USP/EP Pharmaceutical Grade) |
| Assay / Purity | 98.0% – 102.0% |
| Appearance | White to off-white crystalline powder |
| CAS Number | 175865-59-5 |
📝 Safety & Handling: Formulated strictly for controlled pharmaceutical manufacturing, antiviral compounding, and clinical laboratory workflows. Valganciclovir Hydrochloride is a highly potent active substance that exhibits potential teratogenic, mutagenic, and reproductive toxicity risks, and can cause skin, eye, and respiratory tract irritation upon exposure. Therefore, store in a cool, dry, dark location under tight temperature controls away from direct sunlight, moisture, and incompatible organic materials in its original safety-sealed packaging. Prevent airborne powder generation and strictly avoid direct inhalation, skin contact, or accidental ingestion. Operating within a certified powder containment hood, utilizing localized exhaust ventilation, and wearing full laboratory protective equipment (PPE)—including double gloves, protective gowns, and certified particulate respirators—is strictly mandatory. Always consult the Safety Data Sheet (SDS) for comprehensive handling regulations.
